Advaxis Inc (NASDAQ:ADXS)

18.48
Delayed Data
As of Jul 02
 -0.44 / -2.33%
Today’s Change
2.50
Today|||52-Week Range
30.13
+130.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$580.2M

Company Description

Advaxis, Inc. is a clinical-stage biotechnology company, which intends to develop immunotherapies for cancer and infectious diseases. The company's platform technology is designed to generate a comprehensive immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor. Advaxis was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Contact Information

Advaxis, Inc.
305 College Road East
Princeton New Jersey 08540
P:(609) 452-9813
Investor Relations:

Employees

Shareholders

Other institutional32.01%
Individual stakeholders24.24%
Mutual fund holders21.25%

Top Executives

Daniel J. O'ConnorPresident, Chief Executive Officer & Director
Gregory T. MayesCOO, Secretary, EVP & Head-Investor Relations
Sara BonsteinChief Financial Officer & Senior Vice President
Robert PetitChief Scientific Officer & Executive VP
David J. MauroChief Medical Officer & Executive Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account